Ayurvedic medicines are serving the needs of ailing humanity for centuries, but there is a constant need to bring these medicines on a global platform and to give them proper scientific validity. Central council for research in ayurvedic sciences (CCRAS), Ministry of AYUSH, Government of India, since inception is dedicated in the validation of classical Ayurveda formulations through series of clinical studies, to consolidate the use of Ayurveda classical formulations, backed by proper scientific evidence. The Council has generated scientific evidence on clinical safety and efficacy of approximate 100 classical Ayurvedic formulations on 35 diseases/conditions of priority areas. The evidence on clinical efficacy and safety of Ayurvedic formulations which are vogue and available in the market are not only highly useful to practitioners and consumers for their rational use but also will strengthen integration of Ayurveda with other systems of medicine and will be helpful in convincing scientific community across the world which may also improve its market in the country and world at large.
INTRODUCTION
The CCRAS, an autonomous organization of Ministry of AYUSH, Government of India, is the apex body in India for the formulation, coordination, development, and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa systems of medicine. The core research activities comprise of clinical research, medicinal plant research, drug standardization and quality assurance, pharmacological research, literary research and documentation, Public Health oriented research activities (Tribal Health Care Research Program, Swasthya Rakshan Program; Ayurveda Mobile Health Care Program and National Program for control diabetes, cancer, cardiovascular diseases, and stroke). The research activities of the council are carried out through its 30 institutes/centers/ units located all over India (each institute is assigned with a particular mandate for research) and also through collaborative studies with various Universities, Hospitals, and Institutes.
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CCRAS Initiatives Toward Validation of Classical Drugs
In present era, when the cost of health care is constantly rising, it is adversely affecting people's ability to afford health coverage. With increasing concerns regarding numerous side effects of the conventional system of medicine, the world is looking for a safer and better alternative. In such stance, Ayurveda is being looked upon as the most promising answer to the health care problems. It is a time tested safe and effective system of medicine being practices since ages, still having all the above beauties, but it's still lagging behind because of the lack of scientific evidence.
The council since inception is dedicated in the validation of classical Ayurveda formulations through a series of clinical studies to generate proper scientific evidence for clinical safety and efficacy of classical Ayurveda formulations.
In order to generate tangible evidence of classical Ayurveda formulations/therapies for their clinical safety and efficacy; the Council has identified classical Ayurveda formulations for identified disease conditions referring from Ayurvedic pharmacopeia/Ayurvedic formulary of India, essential drug list of ASU medicines (2013), Ministry of AYUSH and other Ayurveda classical texts. These formulations are being validated through Council's institutes engaged in clinical research in a phased manner. Some of the formulations are clinically validated for different disease conditions, and some are used in different combinations for the same or different disease conditions. (Tables 1 and 2 ).
SHORT COMMUNICATION JRAS
Validation of approximate 35 classical Ayurvedic formulations is continuing for generation of scientific evidence on safety and efficacy on 14 diseases/ conditions. The research outcomes of these studies are being published in journals for wider dissemination which may be accessed through Ayurveda Research Portal. 3 Due to lack of scientific validation of classical Ayurveda formulations, this precious science is trailing. Evidence-based research is highly needed for global recognition and acceptance of Ayurveda, hence the evidence generated by the Councils through a series of clinical studies will help in resolution of controversies in Ayurvedic drug and it will not only be beneficial to practitioners and consumers for their rational use but also strengthen integration of Ayurveda with other systems of medicine. It will also help in convincing the scientific community across the world which may also improve its market in the country and world at large.
CONCLUSION
Standardization and validation are the measures to ensure the quality and these include all measures from the manufacturing process and quality control and
proper clinical studies leading to a reproducible quality, safety and efficacy of the drug. Ayurvedic medicines are serving the needs of ailing humanity for centuries, but there is a constant need to bring these medicines on a global platform and to give them proper scientific validity. The Council is dedicatedly working toward this goal and has already validated more than 100 classical drugs in various disease condition of national importance. Further, the council has laid its research policy to meet the objective of quality research in Ayurveda. 4 
